DDX53 and neoplasm: To evaluate the inhibitory effect of mROR1 fusion proteins on tumor growth in vivo, we inoculated the vaccinated mice with fully syngeneic CT26-ROR1+ (8 mice in each group) and 4T1-ROR1+ tumor cells (3 mice in each group).